Inlight Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Inlight Wealth Management's PFE Position: Q1 2026 in Review
Inlight Wealth Management reduced its Pfizer (PFE) stake by 1.7% in Q1 2026, selling an estimated $44.2K and leaving 98,685 shares worth $2.77M. The position accounts for 1.03% of the portfolio, ranked #21.
Inlight Wealth Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.24M in Q4 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Inlight Wealth Management held 98,685 shares of Pfizer worth $2.77M as of Q1 2026.
- Inlight Wealth Management sold 1,660 Pfizer shares in Q1 2026, an estimated $44.2K.
- Pfizer made up 1.03% of Inlight Wealth Management's portfolio in Q1 2026, its #21 holding.
- Inlight Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
- Inlight Wealth Management's Pfizer position peaked at $3.24M in Q4 2024.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Inlight Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.